Maulik Nanavaty is an executive with over 30 years of experience in medical devices across U.S. and international markets. He is the CEO of Anumana and President of Ventures at nference.

Previously, Maulik spent 18 years at Boston Scientific, where he was SVP and President of Neuromodulation, leading a $1B global business. He also held leadership roles as President & Representative Director Boston Scientific Japan and GM Interventional Cardiology Prior to that he spent 16 years at Baxter in executive positions.

Maulik holds a Ph.D. in Pharmaceutical Sciences from the University of Illinois and an M.B.A. from the University of Chicago.